IE
OPRX icon

Israel Englander’s OptimizeRx OPRX Stock Holding History

Israel Englander’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$451K Buy
78,791
+53,476
+211% +$307K ﹤0.01% 4860
2026
Q1 		$159K Sell
25,315
-18,354
-42% -$170K ﹤0.01% 5242
2025
Q4 		$535K Buy
+43,669
New +$714K ﹤0.01% 4898
2025
Q3 		– Sell
-17,593
Closed -$238K – 6339
2025
Q2 		$238K Sell
17,593
-73,013
-81% -$799K ﹤0.01% 5282
2025
Q1 		$785K Buy
+90,606
New +$554K ﹤0.01% 4528
2024
Q4 		– Sell
-45,637
Closed -$352K – 6318
2024
Q3 		$352K Buy
45,637
+28,317
+163% +$252K ﹤0.01% 5099
2024
Q2 		$173K Sell
17,320
-42,586
-71% -$468K ﹤0.01% 5192
2024
Q1 		$728K Sell
59,906
-10,025
-14% -$145K ﹤0.01% 4555
2023
Q4 		$1M Sell
69,931
-67,704
-49% -$650K ﹤0.01% 4168
2023
Q3 		$1.07M Sell
137,635
-43,165
-24% -$470K ﹤0.01% 4137
2023
Q2 		$2.58M Sell
180,800
-149,563
-45% -$2.13M ﹤0.01% 3252
2023
Q1 		$4.83M Buy
330,363
+275,530
+502% +$4.61M ﹤0.01% 2632
2022
Q4 		$921K Sell
54,833
-256,362
-82% -$4.43M ﹤0.01% 4246
2022
Q3 		$4.61M Buy
+311,195
New +$6.15M ﹤0.01% 2973
2022
Q1 		– Sell
-9,384
Closed -$583K – 7321
2021
Q4 		$583K Sell
9,384
-579,407
-98% -$43.9M ﹤0.01% 4915
2021
Q3 		$50.4M Buy
+588,791
New +$36.9M 0.03% 635
2021
Q2 		– Sell
-10,544
Closed -$514K – 6933
2021
Q1 		$514K Buy
+10,544
New +$509K ﹤0.01% 4804
2019
Q3 		– Sell
-25,559
Closed -$414K – 4451
2019
Q2 		$414K Sell
25,559
-72,516
-74% -$979K ﹤0.01% 3359
2019
Q1 		$1.25M Buy
98,075
+45,485
+86% +$591K ﹤0.01% 2722
2018
Q4 		$577K Sell
52,590
-32,373
-38% -$479K ﹤0.01% 2873
2018
Q3 		$1.53M Buy
+84,963
New +$1.07M ﹤0.01% 2622

Other funds holding OPRX

WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

Israel Englander's OPRX Position: Q2 2026 in Review

Israel Englander increased its OptimizeRx (OPRX) stake by 211% in Q2 2026, buying an estimated $307K and bringing the position to 78,791 shares worth $451K. The position accounts for ﹤0.01% of the portfolio, ranked #4860.

Israel Englander first reported a position in OPRX in Q3 2018 and has held it in 21 quarters since. The position peaked at $50.4M in Q3 2021. 112 funds tracked by Wall St. Rank hold OPRX as of Q2 2026.

  • Israel Englander held 78,791 shares of OptimizeRx worth $451K as of Q2 2026.
  • Israel Englander bought 53,476 OptimizeRx shares in Q2 2026, an estimated $307K.
  • OptimizeRx made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #4860 holding.
  • Israel Englander first reported a position in OptimizeRx in Q3 2018 and has held it in 21 quarters since.
  • Israel Englander's OptimizeRx position peaked at $50.4M in Q3 2021.
  • 112 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.